For the quarter ending 2026-03-31, AMPH made $171,171K in revenue. $6,420K in net income. Net profit margin of 3.75%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 171,171 | 183,105 | 191,840 | 174,414 |
| Cost of revenues | 100,849 | 97,435 | 93,194 | 87,924 |
| Gross profit | 70,322 | 85,670 | 98,646 | 86,490 |
| Selling, distribution, and marketing | 11,927 | 10,279 | 11,505 | 10,235 |
| General and administrative | 18,028 | 16,471 | 39,467 | 13,991 |
| Research and development | 26,737 | 23,314 | 22,354 | 20,080 |
| Total operating expenses | 56,692 | 50,064 | 73,326 | 44,306 |
| Income from operations | 13,630 | 35,606 | 25,320 | 42,184 |
| Interest income | 2,400 | 2,423 | 2,246 | 1,921 |
| Interest expense | 6,553 | 6,630 | 6,284 | 6,281 |
| Other income (expenses), net | 575 | 515 | 231 | 1,511 |
| Total non-operating income (expenses), net | -3,578 | -3,692 | -3,807 | -2,849 |
| Income before income taxes | 10,052 | 31,914 | 21,513 | 39,335 |
| Income tax provision | 3,632 | 7,485 | 4,163 | 8,305 |
| Income before equity in losses of unconsolidated affiliate | - | 24,429 | 17,350 | 31,030 |
| Net income | 6,420 | 24,429 | 17,350 | 31,030 |
| Basic EPS | 0.14 | 0.532 | 0.38 | 0.66 |
| Diluted EPS | 0.14 | 0.518 | 0.37 | 0.64 |
| Basic Average Shares | 45,322,000 | 45,908,000 | 46,474,000 | 46,949,000 |
| Diluted Average Shares | 46,458,000 | 47,165,000 | 47,677,000 | 48,128,000 |
Amphastar Pharmaceuticals, Inc. (AMPH)
Amphastar Pharmaceuticals, Inc. (AMPH)